title: Treatment of female sexual dysfunction.
abstract: OBJECTIVE
  To review the pathophysiology and psychology of female sexual dysfunction (FSD) and describe potential prevention and treatment strategies for the disorder.
  
  
  METHODS
  Articles identified from a MEDLINE search (1966-June 2002) using the term female sexual dysfunction. Additional references were obtained from cross referencing retrieved articles.
  
  
  METHODS
  After evaluating various review articles, clinical trials, and investigational studies, all information that was deemed relevant by the reviewers was included.
  
  
  RESULTS
  FSD is a multicausal and multidimensional problem combining biological, psychological, and interpersonal factors. The American Foundation for Urological Disease classifies FSD into 4 broad categories: sexual desire disorders, arousal disorder, orgasmic disorder, and sexual pain disorders. Depending on specific individual characteristics and category of disorder, a variety of potential treatments are available. Pharmacists can play a role in identifying and managing medication-related adverse effects that may be exacerbating FSD and educating women on treatment modalities.
  
  
  CONCLUSIONS
  FSD is a complicated disorder that is often difficult to identify, classify, and treat appropriately. Pharmacists should have an understanding of the potential causes of FSD and the treatment options available so that they may make appropriate recommendations and counsel women effectively.
authors.affiliation: Departments of Pharmacy Practice and Family Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. rguccik@musc.edu
authors.forename: Kelly R
authors.initials: KR
authors.lastname: Ragucci
authors.forename: Nicole S
authors.initials: NS
authors.lastname: Culhane
mesh_terms: D002986:Clinical Trials as Topic; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D012735:Sexual Dysfunction, Physiological / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*